Welsis Corp. (WLSS)
OTCMKTS · Delayed Price · Currency is USD
3.500
+1.570 (81.35%)
At close: Aug 6, 2025
Welsis Market Cap
Welsis has a market cap or net worth of $9.63 million as of October 30, 2025.
Market Cap
9.63M
Enterprise Value
9.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.50
Market Cap Chart
Since September 22, 2023, Welsis's market cap has increased from 2.81M to 9.63M, an increase of 243.14%. That is a compound annual growth rate of 93.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 9.63M | 385.77% |
| Dec 31, 2024 | 1.98M | -29.36% |
| Sep 22, 2023 | 2.81M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 668.66M |
| Glass House Brands | 588.69M |
| Northwest Biotherapeutics | 394.58M |
| Silence Therapeutics | 337.25M |
| CytoDyn | 320.50M |
| Nika Pharmaceuticals | 312.10M |
| American Oncology Network | 291.52M |